27 closest matches · ranked by relevance
Keloid Scar
Primary: To Assess the Impact of an Educational Lecture on Knowledge About Keloid Scars by Comparing Mean Scores Between Knowledge Assessment Questionnaires Administered Before…
Keloid
Primary: Change in Keloid Surface Area — 0.455; -0.039 cm2
Keloid · Hypertrophic Scar · Cicatrix, Hypertrophic
Primary: Change in Lesion Volume — 40; 42; 32 Percent Change
Keloid
Primary: Percentage of Subjects With Confirmed Keloid Formation at Treated vs. Untreated Lesions at 24 Weeks — 92.9; 85.7 percentage of participants
Keloid
Primary: The Primary Purpose of This Study Will be to Gain Preliminary Safety Experience With Apligraf in the Keloid Indication. The Number of Participants Experiencing AEs is…
Keloid Scar
Primary: Change in Patient and Observer Scar Assessment Scale (POSAS) Score From Baseline to Final Visit — -20; -20.6 score on a scale
Scar Prevention · Scar Reduction
Primary: Differences Among the 3 Dosage Groups in the Patient (PSAS) and Observer (OSAS) Scar Assessment Scale (POSAS) Scores — 23.29; 24.11; 21.33; 18.53 Units on a scale — p=0.87
Scar Prevention · Scar Reduction
Primary: Differences Among the 3 Dosage Groups in the Patient (PSAS) and Observer (OSAS) Scar Assessment Scale (POSAS) Scores — 13.3; 17.7; 15.9; 17.1 Units on a scale — p=0.078
Nasolabial Folds
Primary: Number Participants With Hypertropic Scarring, Keloid Formation, Hyper- or Hypopigmentation in Patients With Fitzpatrick Skin Types IV, V, and VI Receiving Nasolabial…
Keloid
Primary: Mean Change in Composite Observer Score for Patient and Observer Scar Assessment Scale (POSAS) — -9.5; -8.9 score on a scale
Scar · Skin Scarring · Skin Cancer
Primary: Cosmetic Outcome — 7.4; 6.6; 6.3; 6.00 score on a scale
Acne Keloidalis Nuchae
Primary: Percentage Change in Total AKN Lesions From Baseline to Week 16. — 49 percentage of lesion count reduction
Reduction of Hypertrophic Skin Scarring
Primary: Physician Global Assessment Using Physician Overall Opinion Question of Patient and Observer Scar Assessment Scale (POSAS) — 4.00; 4.68; 4.61; 4.86 units on scale…
Surgical Incision
Primary: Patient and Observer Scar Assessment Scale (POSAS)- Patient Scores 12M — 1.09; 1.22; 1.3; 1.87 score on a scale
Hypertrophic
Primary: Visual Analogue Scale (VAS) — 2.90; 3.29 score on a scale
Scarring Due to Treatment
Primary: Post-operative Scarring - Erythema — 1.67; 1.70; 1.50; 1.65 score on a scale — p=0.48
Fibrosis · Skin Scarring · Skin Wound
Primary: Change in Scar Pliability Between the Treated and Control Incision Sites as Measured by Skin Elasticity at 6 Months Compared to Baseline
Skin Cancer
Primary: MMSS for Scar Halves Treated — 8.4; 8.7 score on a scale
Scar Formation
Primary: Photography- Independent Scar Assessment Panel
Hypertrophic
Primary: Visual Analogue Scale (VAS) — 3.78; 5.58 Units on a scale
Post-operative Excessive Scarring
Primary: Modified Manchester Scar Scale (MMSS) Score — 8; 11.5 score on a scale
Hidradenitis Suppurativa (HS)
Primary: Percent Change in Wound Size — 57.2 percentage change in wound size
Surgical Scar · Breast Augmentation · Abdominoplasty
Primary: Improvement of Surgical Scars at 12 Months Compared to Baseline (Pre-treatment) as Evaluated by 3 Independent Blinded Reviewers Using the General Aesthetic Improvement…
Acne Scars - Mixed Atrophic and Hypertrophic
Primary: Mean Change From Baseline in Erythema — -1.687; 5.730 units on a scale
Wrinkles
Primary: Keloid Formation at Site of Injection — 0.0 percentage of participants
Breast-Conserving Surgery
Primary: Volume Restoration — 33 Participants
Reduction in Severity of Skin Scarring
Primary: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 8; 0 Participants